ascopubs.org

Impact of excision repair cross-complementation group 1 (ERCC1) protein on survival of patients with osteosarcoma treated with cisplatin-based chemotherapy.

Efficacy of novel proteasome inhibitory platinum complex against osteosarcoma. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...
ascopubs.org

Excision repair cross complementation group 1 (ERCC-1) gene polymorphisms and response to nivolumab in advanced non-small cell lung cancer (NSCLC).

Association of changes in T regulatory cells (Treg) during nivolumab treatment with melanoma outcome. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not ...